American National Bank & Trust’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-688
Closed -$6.66K 679
2025
Q2
$6.66K Buy
688
+600
+682% +$6.19K ﹤0.01% 559
2025
Q1
$1.31K Hold
88
﹤0.01% 561
2024
Q4
$1.31K Hold
88
﹤0.01% 485
2024
Q3
$1.68K Hold
88
﹤0.01% 447
2024
Q2
$1.82K Hold
88
﹤0.01% 517
2024
Q1
$1.65K Buy
+88
New +$1.51K ﹤0.01% 457
2023
Q4
Sell
-915
Closed -$15.9K 651
2023
Q3
$15.9K Sell
915
-305
-25% -$6.36K ﹤0.01% 375
2023
Q2
$25.4K Hold
1,220
﹤0.01% 338
2023
Q1
$28.7K Buy
1,220
+113
+10% +$3.03K 0.01% 326
2022
Q4
$31K Sell
1,107
-7
-0.6% -$179 0.01% 303
2022
Q3
$26K Sell
1,114
-34
-3% -$1.03K 0.01% 288
2022
Q2
$39K Buy
+1,148
New +$40.2K 0.01% 193
2022
Q1
Sell
-1,149
Closed -$35K 440
2021
Q4
$35K Hold
1,149
0.01% 214
2021
Q3
$38K Buy
+1,149
New +$36.8K 0.01% 179

Other funds holding OGN

American National Bank & Trust's OGN Position: Q3 2025 in Review

American National Bank & Trust sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 688 shares — an estimated $6.66K sold.

American National Bank & Trust first reported a position in OGN in Q3 2021 and held it in 14 quarters. The position peaked at $39K in Q2 2022. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • American National Bank & Trust reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
  • American National Bank & Trust sold 688 Organon & Co shares in Q3 2025, an estimated $6.66K.
  • American National Bank & Trust first reported a position in Organon & Co in Q3 2021 and held it in 14 quarters.
  • American National Bank & Trust's Organon & Co position peaked at $39K in Q2 2022.
  • 670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on American National Bank & Trust's 13F filing for Q3 2025, filed 21 Oct 2025.